These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6533295)

  • 1. Concentration and pH dependent steady-state volume of distribution of methotrexate estimated by a simple physiologically based method.
    Lui CY; Lee MG; Chiou WL
    J Pharmacokinet Biopharm; 1984 Dec; 12(6):597-610. PubMed ID: 6533295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary pH and urine flow independent renal clearance of methotrexate in dogs.
    Lui CY; Lee MG; Chiou WL
    J Pharmacokinet Biopharm; 1985 Apr; 13(2):159-71. PubMed ID: 4057055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clearance studies of methotrexate in dogs after multiple-rate infusion.
    Lui CY; Lee MG; Chiou WL
    Cancer Res; 1985 Apr; 45(4):1545-8. PubMed ID: 3978622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics of methotrexate after intravenous administration of methotrexate-loaded proliposomes to rats.
    Park JM; Ahn BN; Yoon EJ; Lee MG; Shim CK; Kim CK
    Biopharm Drug Dispos; 1994 Jul; 15(5):391-407. PubMed ID: 7981428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic studies of methotrexate in plasma and synovial fluid following i.v. bolus and topical routes of administration in dogs.
    Lu GW; Jun HW; Dzimianski MT; Qiu HC; McCall JW
    Pharm Res; 1995 Oct; 12(10):1474-7. PubMed ID: 8584484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of methotrexate after intravenous and intramuscular injection of methotrexate-bearing positively charged liposomes to rats.
    Kim MM; Lee SH; Lee MG; Hwang SJ; Kim CK
    Biopharm Drug Dispos; 1995 May; 16(4):279-93. PubMed ID: 7548777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate in rabbits after intravenous administration.
    Chen ML; Chiou WL
    J Pharmacokinet Biopharm; 1983 Oct; 11(5):499-513. PubMed ID: 6668556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of renal tubular transport of methotrexate by probenecid.
    Bourke RS; Chheda G; Bremer A; Watanabe O; Tower DB
    Cancer Res; 1975 Jan; 35(1):110-6. PubMed ID: 1109785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate cerebrospinal fluid and serum concentrations after intermediate-dose methotrexate infusion.
    Evans WE; Hutson PR; Stewart CF; Cairnes DA; Bowman WP; Rivera G; Crom WR
    Clin Pharmacol Ther; 1983 Mar; 33(3):301-7. PubMed ID: 6600662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bolus and maintenance infusion of high-dose methotrexate].
    Amino K; Kawaguchi N; Matsumoto S; Manabe J; Tabata D; Machida M
    Gan To Kagaku Ryoho; 1989 May; 16(5):2045-9. PubMed ID: 2730094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose methotrexate in children with acute lymphoblastic leukemia: 7-hydroxymethotrexate systemic exposure and urinary concentrations at the steady state correlate well with those of methotrexate.
    Chládková J; Hak J; Martínková J; Chládek J
    Arzneimittelforschung; 2010; 60(12):769-75. PubMed ID: 21265469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pharmacokinetic model for predicting the concentration of methotrexate in plasma subsequent to intrathecal injection.
    Ramu A; Fusner JE
    Isr J Med Sci; 1979 Jun; 15(6):494-9. PubMed ID: 582316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clearance studies of methotrexate and 7-hydroxy-methotrexate in rabbits after multiple-dose infusion.
    Chen ML; Chiou WL
    J Pharmacokinet Biopharm; 1983 Oct; 11(5):515-27. PubMed ID: 6668557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics in blood IV: unusual distribution, storage effect and metabolism of methotrexate.
    Lee MG; Lui CY; Chen ML; Chiou WL
    Int J Clin Pharmacol Ther Toxicol; 1984 Oct; 22(10):530-7. PubMed ID: 6511128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theoretically required urinary flow during high-dose methotrexate infusion.
    Sasaki K; Tanaka J; Fujimoto T
    Cancer Chemother Pharmacol; 1984; 13(1):9-13. PubMed ID: 6733846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient characteristics associated with high-risk methotrexate concentrations and toxicity.
    Relling MV; Fairclough D; Ayers D; Crom WR; Rodman JH; Pui CH; Evans WE
    J Clin Oncol; 1994 Aug; 12(8):1667-72. PubMed ID: 8040679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate-induced renal impairment: clinical studies and rescue from systemic toxicity with high-dose leucovorin and thymidine.
    Abelson HT; Fosburg MT; Beardsley GP; Goorin AM; Gorka C; Link M; Link D
    J Clin Oncol; 1983 Mar; 1(3):208-16. PubMed ID: 6607976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis.
    van Ede AE; Laan RF; Blom HJ; Boers GH; Haagsma CJ; Thomas CM; De Boo TM; van de Putte LB
    Rheumatology (Oxford); 2002 Jun; 41(6):658-65. PubMed ID: 12048292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate test-dose protocol in the presence of 7-hydroxy-methotrexate.
    Lena N; Imbert AM; Favre R; Cano JP; Carcassonne Y
    Eur J Cancer Clin Oncol; 1987 May; 23(5):481-5. PubMed ID: 3477455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of concomitant aspirin or prednisone on methotrexate synovial fluid concentration.
    Stewart CF; Christensen ML; Evens RP; Cremer M; Evans WE
    J Pharmacol Exp Ther; 1987 Oct; 243(1):131-7. PubMed ID: 3668846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.